JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

Search

Stryker Corp

Geschlossen

BrancheGesundheitswesen

376.65 -0.28

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

374.8

Max

378.97

Schlüsselkennzahlen

By Trading Economics

Einkommen

884M

1.5B

Verkäufe

156M

6B

KGV

Branchendurchschnitt

49.999

34.393

EPS

3.13

Dividendenrendite

0.88

Gewinnspanne

25.54

Angestellte

53,000

EBITDA

179M

1B

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+15% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

0.88%

2.54%

Nächstes Ergebnis

28. Okt. 2025

Nächste Dividendenausschüttung

31. Okt. 2025

Nächstes Ex-Dividendendatum

30. Sept. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-7.3B

146B

Vorheriger Eröffnungskurs

376.93

Vorheriger Schlusskurs

376.65

Nachrichtenstimmung

By Acuity

40%

60%

131 / 374 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Weak Bullish Evidence

Stryker Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

31. Juli 2025, 20:42 UTC

Ergebnisse

Stryker Lifts Guidance on Improving Tariff Outlook

1. Mai 2025, 20:56 UTC

Ergebnisse

Stryker Lowers Adjusted EPS View on $200 Million Tariff Impact

28. Jan. 2025, 21:55 UTC

Ergebnisse

Stryker Sees Further Organic Sales Growth in 2025

28. Jan. 2025, 21:46 UTC

Akquisitionen, Fusionen, Übernahmen

Stryker to Sell Spinal Implants Business to Viscogliosi Brothers

31. Juli 2025, 20:09 UTC

Ergebnisse

Stryker Estimates Net Impact From Tariffs in 2025 of Approximately $175M

31. Juli 2025, 20:09 UTC

Ergebnisse

Stryker Sales >SYK

31. Juli 2025, 20:09 UTC

Ergebnisse

Stryker Sees FY25 Organic Net Sales Up 9.5%-10%

31. Juli 2025, 20:05 UTC

Ergebnisse

Stryker 2Q Sales $6B >SYK

31. Juli 2025, 20:05 UTC

Ergebnisse

Stryker 2Q Net $884M >SYK

31. Juli 2025, 20:05 UTC

Ergebnisse

Stryker Sees FY Adj EPS $13.40-Adj EPS $13.60 >SYK

31. Juli 2025, 20:05 UTC

Ergebnisse

Stryker 2Q EPS $2.29 >SYK

31. Juli 2025, 20:05 UTC

Ergebnisse

Stryker 2Q Adj EPS $3.13 >SYK

31. Juli 2025, 20:05 UTC

Ergebnisse

Stryker 2Q Sales $6B >SYK

31. Juli 2025, 20:05 UTC

Ergebnisse

Stryker 2Q EPS $2.29 >SYK

31. Juli 2025, 20:05 UTC

Ergebnisse

Stryker 2Q EPS $2.29 >SYK

1. Mai 2025, 20:41 UTC

Ergebnisse

Stryker Lowers Adjusted EPS View on $200M Tariff Impact

1. Mai 2025, 20:11 UTC

Ergebnisse

Stryker Cuts FY25 View To Adj EPS $13.20-Adj EPS $13.45 >SYK

1. Mai 2025, 20:10 UTC

Ergebnisse

Stryker Raising FY25 Organic Net Sales Growth Guidance Range to 8.5% to 9.5% >SYK

1. Mai 2025, 20:05 UTC

Ergebnisse

Stryker 1Q Adj EPS $2.84 >SYK

1. Mai 2025, 20:05 UTC

Ergebnisse

Stryker 1Q Net $654M >SYK

1. Mai 2025, 20:05 UTC

Ergebnisse

Stryker 1Q EPS $1.69 >SYK

1. Mai 2025, 20:05 UTC

Ergebnisse

Stryker 1Q Sales $5.87B >SYK

1. Mai 2025, 20:05 UTC

Ergebnisse

Stryker 1Q EPS $1.69 >SYK

19. Feb. 2025, 13:53 UTC

Akquisitionen, Fusionen, Übernahmen

Stryker Files 8K - Asset Acquisition Or Disposition >SYK

19. Feb. 2025, 13:30 UTC

Akquisitionen, Fusionen, Übernahmen

Stryker Completes Acquisition Of Inari Medical, Inc., Providing Entry Into The High-growth Peripheral Vascular Segment >SYK

28. Jan. 2025, 21:09 UTC

Akquisitionen, Fusionen, Übernahmen

Stryker: Transaction Is Expected to Close in the U.S. in 1H 2025 >SYK

28. Jan. 2025, 21:09 UTC

Akquisitionen, Fusionen, Übernahmen

Stryker: Agreement Includes Binding Offer to Acquire Stryker's Spinal Implants Business in France >SYK

28. Jan. 2025, 21:08 UTC

Akquisitionen, Fusionen, Übernahmen

Stryker: After Closing, VB Spine Will Become a Strategic Partner to Stryker With Exclusive Access to Mako Spine and Copilot for Use With VB Spine's Implants in Spine Procedures >SYK

28. Jan. 2025, 21:08 UTC

Akquisitionen, Fusionen, Übernahmen

Stryker: Agreement to Sell U.S. Spinal Implants Business to Viscogliosi Brothers, LLC to Create Newly Formed Co Called VB Spine, LLC >SYK

28. Jan. 2025, 21:06 UTC

Ergebnisse

Stryker Sees Organic Net Sales Growth of 8% to 9% for 2025 >SYK

Peer-Vergleich

Kursveränderung

Stryker Corp Prognose

Kursziel

By TipRanks

15% Vorteil

12-Monats-Prognose

Durchschnitt 434.21 USD  15%

Hoch 456 USD

Tief 407 USD

Basierend auf 17 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Stryker Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

17 ratings

13

Buy

4

Halten

0

Sell

Technischer Score

By Trading Central

373.92 / 383.99Unterstützung & Widerstand

Kurzfristig

Weak Bullish Evidence

Mittelfristig

Bullish Evidence

Langfristig

Bullish Evidence

Stimmung

By Acuity

131 / 374 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.